Skip to content

    Mineralys Therapeutics (MLYS) stock price & financials

    View MLYS earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+68.3% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    Operating Profit
    -$60.11M
    -$51.77M
    -$44.45M
    -$46.75M
    -$41.13M
    +31.6%
    -$38.28M
    +26.1%
    -$45.34M
    -2.0%
    -$246.04M
    -426.3%
    Weakening
    Net Profit
    -$56.34M
    -$48.95M
    -$42.21M
    -$43.27M
    -$36.93M
    +34.5%
    -$32.23M
    +34.1%
    -$39.34M
    +6.8%
    -$241.07M
    -457.1%
    Weakening
    EPS
    $-1.13
    $-0.79
    $-0.66
    $-0.52
    +54.0%
    $-0.47
    +40.5%
    $-2.85
    -331.8%
    Weakening
    Other Income
    $3.76M
    $2.82M
    $2.24M
    $3.47M
    $4.20M
    +11.6%
    $6.05M
    +114.3%
    $6.00M
    +168.4%
    $4.97M
    +43.1%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    MarginsOPM
    Tax
    ReturnsROIC
    7.6%
    6.6%
    5.7%
    5.9%
    5.0%
    -34.5%
    4.4%
    -34.1%
    5.3%
    -6.8%
    32.7%
    +457.1%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY22FY23FY24FY25TTM
    AssetsCash & Equivalents$87.70M$49.30M$114.09M$172.92M$138.27M
    Short-Term Investments
    Total Current Assets$112.81M$249.10M$205.35M$661.39M$665.80M
    Net PP&E$0$53.0K$38.0K$27.0K
    Goodwill
    Intangibles
    Total Assets$114.44M$251.64M$205.90M$661.81M$667.85M
    LiabilitiesTotal Current Liabilities$8.07M$10.48M$14.65M$15.11M$19.32M
    Short-Term Debt
    Long-Term Debt$100.0K
    Long-Term Leases
    Total Liabilities$166.71M$10.48M$14.65M$15.11M$116.94M
    EquityCommon Stock & APIC$1.0K$4.0K$5.0K$8.0K$9.0K
    Retained Earnings-$52.81M-$124.71M-$302.52M-$457.17M-$737.58M
    Total Equity-$52.27M$241.15M$191.26M$646.69M$550.92M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$29.22M-$81.17M-$166.31M-$142.42M-$138.79M
    Cash from Investing-$21.76M-$160.47M$114.96M-$389.75M-$484.16M
    Cash from Financing$128.02M$203.25M$116.14M$591.00M$659.42M
    SummaryCapital Expenditure$0-$96.0K-$15.0K
    Free Cash Flow-$81.17M-$166.41M-$142.43M
    FCF Margin

    Ratios